Neil F. McFarlane

Neil F. McFarlane has served as a member of the Board of Managers of HCRx Holdings since January 2024. Mr. McFarlane is the President, Chief Executive Officer and member of the board of directors of Zevra Therapeutics. He previously served as the Chief Executive Officer and a member of the Board of Directors for Adamas Pharmaceuticals until November 2021, when Adamas was acquired by Supernus Pharmaceuticals. Prior to Adamas, Mr. McFarlane served as the Chief Operating Officer of Retrophin (now Travere Therapeutics). Prior to his position at Retrophin, Mr. McFarlane held positions of increasing responsibility with UCB, Genzyme (now Sanofi) and Sangstat Medical (acquired by Genzyme). Mr. McFarlane currently serves on the Board of Directors for Collegium Pharmaceuticals. He proudly served as an officer and enlisted soldier in the United States Army Reserves, and earned his B.S. and M.S. in Nursing from the University of Florida.